Correlation Between AVRO Old and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both AVRO Old and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AVRO Old and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AVRO Old and Biomarin Pharmaceutical, you can compare the effects of market volatilities on AVRO Old and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AVRO Old with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of AVRO Old and Biomarin Pharmaceutical.
Diversification Opportunities for AVRO Old and Biomarin Pharmaceutical
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between AVRO and Biomarin is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding AVRO Old and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and AVRO Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AVRO Old are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of AVRO Old i.e., AVRO Old and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between AVRO Old and Biomarin Pharmaceutical
If you would invest 6,244 in Biomarin Pharmaceutical on December 4, 2024 and sell it today you would earn a total of 858.00 from holding Biomarin Pharmaceutical or generate 13.74% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
AVRO Old vs. Biomarin Pharmaceutical
Performance |
Timeline |
AVRO Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Biomarin Pharmaceutical |
AVRO Old and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AVRO Old and Biomarin Pharmaceutical
The main advantage of trading using opposite AVRO Old and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AVRO Old position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.AVRO Old vs. Ocean Biomedical | AVRO Old vs. Enveric Biosciences | AVRO Old vs. Elevation Oncology | AVRO Old vs. Zura Bio Limited |
Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |